It would be interesting to know where they are at with omomyc Last i heard they had found omomyc had inherant cell penetrating capabilities and they were looking at a nasal spray?? I wonder if they have developed targetted cell penetrating and endosomal escape or if they are sticking to this earlier path. I dont recall which cancer types they were targetting with the nasal spray approach.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.015(1.16%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.31 | $3.202K | 2.444K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 3137 | 1 |
View Market Depth
| Last trade - 09.59am 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |